What is an injection moulding company worth?

An injection moulding plant does not sell a product line the way a manufacturer of branded goods does — it sells process capacity against a customer’s mould and specification. That distinction is the starting point for value: a buyer is not pricing what the plant makes this year so much as how confidently that press capacity keeps running next year, and on whose terms. Two plants with identical revenue and an identical press count can carry very different price tags once a buyer looks past utilization at what is actually holding that revenue together.

What a buyer is actually pricing

The core of the valuation is the press fleet measured against the customer programs actually running on it — tonnage, age and how well matched the two are, since idle capacity and over-tonnage presses running small parts both signal a mismatch a buyer has to fix. Program stability sits alongside capacity: a plant built on a small number of long-running production programs is priced very differently from one running the same revenue through frequent one-off jobs, because forward revenue is easier to underwrite when the programs are already proven. In-house secondary operations — assembly, pad printing, ultrasonic welding — add margin per part and are valued as a real capability, not an afterthought, and resin-purchasing scale matters because a plant that buys material at genuine volume carries less input-cost exposure than one buying small lots at spot pricing.

Mould ownership changes the balance sheet a buyer trusts

Moulds are frequently customer property held and maintained by the moulder rather than owned outright, and a buyer’s advisor will separate the two categories carefully before accepting the asset base at face value. A mould inventory that is documented — condition, maintenance history, which customer owns which tool — supports the numbers on the page. An undocumented inventory does the opposite: it raises the question of whether tooling booked as a company asset actually belongs to a customer, which is not a cosmetic issue but a direct overstatement of what is being sold, and a serious buyer will want that reconciled before pricing proceeds any further.

How earnings get recast for a moulding business

Recasting starts by separating revenue on long-running programs, which a buyer can reasonably extend forward, from one-off or short-run jobs that will not repeat. From there the usual add-backs apply — above-market owner compensation, a vehicle run through the business, one-time capital items — but a moulding-specific step follows: how resin price movement flows through the business. A plant that passes resin cost changes through to its customers under the program agreement carries a more stable margin than one that absorbs those swings itself, and a buyer’s advisor will typically model both a pass-through and an absorbed scenario before settling on a working number, since the gap between them can be considerable.

Programs tied to a regulated end-customer carry a different value calculus

Some moulding programs run parts into a food-contact or medical-device end product, which pulls the plant into the customer’s own Health Canada or CFIA-adjacent supplier-quality requirements even though the moulder itself never holds that registration directly. That flow-down obligation cuts two ways on price: the added qualification barrier makes the program stickier for a competitor to win away, which supports a stronger value on that revenue, but it also raises the documentation standard a buyer inherits, and a buyer’s advisor will want to see the supplier-quality audit history behind the program before crediting the premium it otherwise justifies.

Why the discounts matter as much as the drivers

A small number of customer programs carrying most of the press hours is the single biggest discount in this sub-sector, because losing one program can idle a large share of capacity at once, and a buyer prices that concentration risk directly against the asking number. A press fleet aging past its expected service life without a funded capital-replacement plan is priced as a near-term cash outlay layered on top of the purchase price, not a future problem. Scrap and regrind handling that has never been reviewed for environmental or waste-diversion compliance is a smaller line item on its own, but it signals to a buyer that other operational and compliance housekeeping may be equally unreviewed, and that suspicion tends to widen the discount beyond what the single issue would justify alone.

How the buyer sitting across the table changes the number

The mechanics above assume one buyer profile, but who is actually bidding changes how those factors get weighed. Another injection moulder consolidating press capacity prices the plant largely on its own operational merits — program stability, mould documentation, resin discipline — because it is absorbing the plant into an existing operation it already understands. A contract manufacturer vertically integrating moulding capability, or a strategic customer buying a key supplier to secure its own capacity, may price the same plant differently: continuity of the specific programs matters to them more than it would to a pure financial buyer, and they may accept more concentration risk than an outside buyer would because the concentration is with them. A private equity platform building a plastics-processing group tends to apply a more standardized, EBITDA-driven lens across every plant it looks at, which can produce a cleaner but less generous number than a strategic buyer chasing a specific program or customer relationship.